Erin W. Hofstatter, MD, assistant professor of medicine (medical oncology), co-director, Genetic Counseling Program, Yale Cancer Center, discusses a study to determine if perceived personal breast cancer risk was associated with adherence to healthy lifestyle habit.
Erin W. Hofstatter, MD, assistant professor of medicine (medical oncology), co-director, Genetic Counseling Program, Yale Cancer Center, discusses a study to determine if perceived personal breast cancer risk was associated with adherence to healthy lifestyle habit.
Hofstatter says right now, the American Cancer Society recommends individuals eat 2.5 cups of fruits and vegetables per day, get 75-150 minutes of moderate to vigorous exercise per week, and limit their alcohol intake to roughly one serving per day or less.
In order to determine if women who felt they were more at risk of developing breast cancer were more likely to follow the guidelines, Hofstatter and colleagues used the National Health Interview Survey.
The study showed that most women do not adhere to the US prevention guidelines at all, even if they perceive themselves to be at high risk. Hofstatter says about 95% of women are adherent to the alcohol guideline but only about a third of all women adhere to the exercise guideline. Also, only 5% or less of women were getting the recommended serving of fruits and vegetables each day.
Hofstatter says she is unsure if women know about the guidelines and are not following them or if they are unaware that exercise and diet have anything to do with breast cancer risk.
Workflow, Educational Tools Improve Use of Silicone Film to Prevent Radiation Dermatitis
April 25th 2024Tools to educate oncology nurses and patients on the use of Mepitel film to prevent radiation dermatitis has improved the workflow around its introduction to patients with breast cancer, as well as its application and maintenance.
Olaparib Plus Chemo May Not Improve Outcomes vs Chemo Alone in BRCA Wild-Type TNBC
April 23rd 2024Patients with BRCA wild-type triple-negative breast cancer treated with olaparib on a gap schedule with chemotherapy did not experience improved responses compared with chemotherapy alone in the neoadjuvant setting.
Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium
January 16th 2023Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.